Search
× Search

Urticaria (Hives)/Angioedema (Tissue Swelling)

Urticaria (Hives)/Angioedema (Tissue Swelling)

Most “hives” are caused by histamine and other mediators “released” in the upper layers of the skin.

Histamine can be released from special cells, mast cells and basophils, which are found in everyone’s skin.

Patients with hives release “too much” histamine when it is not needed and are classified as:

  • “Acute hivers” only when they take in an identifiable “trigger”, i.e., drug, food, etc. or if hives last less than 6 weeks.
  • “Chronic hivers” daily or almost daily without an identifiable “trigger” and lasting for greater than six weeks.

In “chronic” urticaria or persistent hives, a “trigger” is rarely found. A “complete” history is needed to look for identifiable “triggers”.

The etiology for chronic urticaria such as medication, heat, pressure or infection is found in less than 5% of patients.

For most cases of chronic urticaria the etiology will remain idiopathic (cause unknown) although an autoimmune etiology can sometimes be found.

  • Angioedema (tissue swelling), occurs in 90% of patients with chronic urticaria

For chronic urticaria laboratory evaluation can be performed: Thyroid auto-antibody profile, CU Index, complete metabolic profile, complete blood count and autoimmunity tests.

Fortunately, most chronic hives go away with or without treatment:

  • 50% of patients hives go away in 3-12 months
  • 20% of patients hives go away in 12-36 months
  • 20% of patients hives go away in 36-60 months
  • 1.5% of patients can have hives for up to 25 years

60% of “chronic” hivers have recurrences of the hives

Management is directed toward keeping patients “comfortable” with or without some hives being present. This can be achieved with “appropriate” antihistamine therapy, and occasionally with “other” medications. Prednisone (steroid) should be avoided if at all possible.

Remember the potency of:

  • Benadryl 50mg. is considered — a strength of 1
  • Clarinex, Claritin, Allegra — a strength of 2-3
  • Atarax (hydroxyzine 25mg.), Zyrtec, Xyzal — a strength of 88
  • Doxepin (Sinequan) 25mg — a strength of 779

 

Recent News

Should a patient delay allergen immunotherapy (AIT) because they are receiving one of the mRNA COVID 19 vaccines?
SuperUser Account
/ Categories: News

Should a patient delay allergen immunotherapy (AIT) because they are receiving one of the mRNA COVID 19 vaccines?

It is suggested that the two shots not be given within 48 hours to avoid confusion in the unlikely event that a reaction occurs to either injection. However, there is no medical contraindication to receiving both. For example, if a patient receives an allergy injection and then an opportunity to receive the COVID-19 vaccine arises the next day, the vaccine doesn’t have to be delayed due to having received an allergy shot the day before.

The post Should a patient delay allergen immunotherapy (AIT) because they are receiving one of the mRNA COVID 19 vaccines? appeared first on Oklahoma Allergy and Asthma Clinic.

Previous Article Oklahoma City Ranks Ninth for Most Challenging Cities for Allergies
Next Article Spring 2021 Allergist Newsletter
Print
35
Terms Of UsePrivacy StatementCopyright 2026 by Oklahoma Allergy and Asthma Clinic
Back To Top